KR100894365B1 - 당뇨병 환자에서 심실 심근 기능을 개선하기 위한 분지쇄아미노산에 기초한 조성물 - Google Patents

당뇨병 환자에서 심실 심근 기능을 개선하기 위한 분지쇄아미노산에 기초한 조성물 Download PDF

Info

Publication number
KR100894365B1
KR100894365B1 KR1020037016184A KR20037016184A KR100894365B1 KR 100894365 B1 KR100894365 B1 KR 100894365B1 KR 1020037016184 A KR1020037016184 A KR 1020037016184A KR 20037016184 A KR20037016184 A KR 20037016184A KR 100894365 B1 KR100894365 B1 KR 100894365B1
Authority
KR
South Korea
Prior art keywords
amino acids
composition
active ingredients
molecular weight
branched chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020037016184A
Other languages
English (en)
Korean (ko)
Other versions
KR20040008217A (ko
Inventor
프랑코 콘티
프란세스코사베리오 디오구르아디
Original Assignee
프로페셔날 디에테틱스 에스.알.엘.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프로페셔날 디에테틱스 에스.알.엘. filed Critical 프로페셔날 디에테틱스 에스.알.엘.
Publication of KR20040008217A publication Critical patent/KR20040008217A/ko
Application granted granted Critical
Publication of KR100894365B1 publication Critical patent/KR100894365B1/ko
Assigned to 디터미넌츠 오브 메타볼리즘 리서치 라보라토리 에스.알.엘. reassignment 디터미넌츠 오브 메타볼리즘 리서치 라보라토리 에스.알.엘. 권리의 전부이전등록 Assignors: 프로페셔날 디에테틱스 에스.피.에이.
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020037016184A 2001-06-15 2002-06-10 당뇨병 환자에서 심실 심근 기능을 개선하기 위한 분지쇄아미노산에 기초한 조성물 Expired - Fee Related KR100894365B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITTO2001A000580 2001-06-15
IT2001TO000580A ITTO20010580A1 (it) 2001-06-15 2001-06-15 Composizioni a base di aminoacidi per il miglioramento della funzioneventricolare miocardica in pazienti affetti da diabete.
PCT/IB2002/002149 WO2002102360A2 (en) 2001-06-15 2002-06-10 Compositions based on branched chain amino acids for improving the myocardial ventricular function in patients suffering from diabetes

Publications (2)

Publication Number Publication Date
KR20040008217A KR20040008217A (ko) 2004-01-28
KR100894365B1 true KR100894365B1 (ko) 2009-04-22

Family

ID=11458964

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020037016184A Expired - Fee Related KR100894365B1 (ko) 2001-06-15 2002-06-10 당뇨병 환자에서 심실 심근 기능을 개선하기 위한 분지쇄아미노산에 기초한 조성물

Country Status (12)

Country Link
US (2) US20040157903A1 (https=)
EP (1) EP1399139B1 (https=)
JP (1) JP4364632B2 (https=)
KR (1) KR100894365B1 (https=)
AU (1) AU2002309122A1 (https=)
CA (1) CA2448745C (https=)
CY (1) CY1115918T1 (https=)
DK (1) DK1399139T3 (https=)
ES (1) ES2527527T3 (https=)
IT (1) ITTO20010580A1 (https=)
PT (1) PT1399139E (https=)
WO (1) WO2002102360A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20030789A1 (it) 2003-10-07 2005-04-08 Professional Dietetics Srl Composizione a base di amino acidi per il trattamento
EP1537864A1 (de) * 2003-12-03 2005-06-08 Franz-Peter Dr. Liebel Verwendung von Aminosäuren und schwefeltragenden Verbindungen zur Prophylaxe und Therapie des UDP-Glucuronosyltransferase1-defizitären Diabetes mellitus Typ II
EP1537865A1 (de) * 2003-12-03 2005-06-08 Franz-Peter Dr. Liebel Verwendung von schwefelhaltigen Verbindungen und proteolytischen Enzymen zur Prophylaxe und Therapie des UDP-Glucuronosyl-transferase 1-defizitären Diabetes mellitus Typ II
US20080032915A1 (en) * 2004-02-12 2008-02-07 Campina Nederland Holding B.V. Cysteine Rich Peptides for Improving Thiol Homeostasis
JP2008056566A (ja) * 2004-12-28 2008-03-13 Toudai Tlo Ltd 低酸素応答促進剤
PL1983849T3 (pl) * 2006-01-20 2013-09-30 Innova Food Ab Kompozycja spożywcza zawierająca aminokwasy
AU2007331447B2 (en) * 2006-12-15 2012-09-06 Tima Foundation Novel compositions and uses thereof
US8633192B2 (en) 2006-12-15 2014-01-21 Tima Foundation Compositions and uses thereof
US8795973B2 (en) * 2010-11-29 2014-08-05 University of Leceister Methods for identifying inhibitors of mannan-binding lectin associated serine protease (MASP) proteins and uses thereof
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
IT201700087359A1 (it) * 2017-07-28 2019-01-28 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
IL296055A (en) 2017-08-14 2022-10-01 Axcella Health Inc Amino acid compositions for the treatment of liver disease
MA52971A (fr) 2018-06-20 2021-04-28 Axcella Health Inc Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04264024A (ja) * 1990-10-30 1992-09-18 Nb Internatl Technol 虚血性心臓組織の保護および代謝回復のための方法および組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053589A (en) * 1975-11-24 1977-10-11 Control Drug Inc. Method of treating nutritional deficiency during cardiac cachexia, diabetes, hypoglycemia, gastroenterology, lipid, cell glycogen and keratin-related skin conditions and alcoholism
JPS60255722A (ja) 1984-05-30 1985-12-17 Otsuka Pharmaceut Factory Inc 糖尿病用アミノ酸輸液
US5032608A (en) * 1986-09-10 1991-07-16 Dudrick Stanley J Method and substrate composition for treating atherosclerosis
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
US5276018A (en) * 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
LU88369A1 (fr) * 1993-07-12 1994-04-01 Michel Urso Prof Medecin Et Ch Acides aminés à chaînes ramifiées
IT1289754B1 (it) * 1996-12-16 1998-10-16 Professional Dietetics Srl Composizioni a base di aminoacidi
IT1320782B1 (it) * 2000-07-04 2003-12-10 Professional Dietetics Srl Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca.
IT1320783B1 (it) * 2000-07-04 2003-12-10 Professional Dietetics Srl Composizioni a base di aminoacidi, atte al miglioramento delleprestazioni muscolari.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04264024A (ja) * 1990-10-30 1992-09-18 Nb Internatl Technol 虚血性心臓組織の保護および代謝回復のための方法および組成物

Also Published As

Publication number Publication date
US20040157903A1 (en) 2004-08-12
DK1399139T3 (en) 2015-01-12
EP1399139A2 (en) 2004-03-24
CY1115918T1 (el) 2017-01-25
CA2448745A1 (en) 2002-12-27
AU2002309122A1 (en) 2003-01-02
WO2002102360A2 (en) 2002-12-27
JP2004534073A (ja) 2004-11-11
US8653136B2 (en) 2014-02-18
WO2002102360A3 (en) 2003-05-30
JP4364632B2 (ja) 2009-11-18
PT1399139E (pt) 2015-01-14
ES2527527T3 (es) 2015-01-26
EP1399139B1 (en) 2014-10-15
KR20040008217A (ko) 2004-01-28
ITTO20010580A1 (it) 2002-12-15
CA2448745C (en) 2012-09-04
US20080194665A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
US8653136B2 (en) Compositions based on amino acids for improving the myocardial ventricular function in patients suffering from diabetes
Yeun et al. Factors influencing serum albumin in dialysis patients
Green et al. Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans
Aronson Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes
Zusman et al. The effect of chronic sodium loading and sodium restriction on plasma prostaglandin A, E and F concentrations in normal humans
CA2208047C (en) Increasing creatine and glycogen concentration in muscle
JP2873497B2 (ja) 脂質代謝調節剤
EP1087779A2 (en) Compositions for increasing energy in vivo
CA2211006A1 (en) Topically applied pharmaceutical composition, method of preparing it and its use
JPH09512552A (ja) 腎疾患および不全の治療方法ならびに組成物
Brouhard et al. Somatostatin limits rise in glomerular filtration rate after a protein meal
Schuback et al. Effect of creatine supplementation on muscle metabolic response to a maximal treadmill exercise test in Standardbred horses
CA2263184C (en) Methods and compositions for increasing the anaerobic working capacity in tissues
Movilli et al. Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients
RU2123011C1 (ru) Крахмал типа декстрина, способ его производства и энергетическая композиция
Rizk et al. Evaluation of clinical activity and safety of Daflon 500 mg in type 2 diabetic female patients
Kita et al. Hemodynamic and hormonal effects of exogenous adrenomedullin administration in humans and relationship to insulin resistance
JP6283054B2 (ja) 生体内のメイラード反応抑制剤またはＡＧＥｓ生成抑制剤
Jórgcnsen Actions of fenfluramine on glucose uptake in vitro and in vivo
Johnson et al. Bioavailability of digoxin from rapidly dissolving preparations
JP6170653B2 (ja) トラネキサム酸を含有する生体内のメイラード反応抑制剤組成物
ISHII et al. A Comparative Study on the Hemodynamic, Renal and Endocrine Effects of α-human Atrial Natriuretic Polypeptide in Normotensive Persons and Patients with Essential Hypertension: THE 15th CONFERENCE ON THE PATHOGENESIS OF HYPERTENSION
Chernow et al. Endocrine responses to critical illness
Wilkes et al. The effect of an elevated maternal lysine concentration on placental lysine transport in pregnant sheep
Méndez NEW PERSPECTIVES ON THE RESEARCH AND TREATMENT OF TYPE 2 DIABETES MELLITUS AND ITS COMPLICATIONS. THE ROLE OF L-ARGININE AND POLYAMINES

Legal Events

Date Code Title Description
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20130321

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20140320

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20160318

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

FPAY Annual fee payment

Payment date: 20170407

Year of fee payment: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20180415

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20180415